Search results for: France
Filter search results
Socio-Economic Value of Adult Immunisation Programmes
18 April 2024
…in ten countries (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, and the United States of America). Results are based on: A targeted literature review of the published…
Spotlight on OHE: Adaptive Pathways, Economic Evaluation, Stated Preferences and Life-cycle Price Modelling
5 November 2014
…to look closely at models of health economic evaluation in France, Germany and the UK. This presentation can be watched here https://www.youtube.com/watch?v=AyoScR9BjuU, from 00:29:27 to 1:28:00. Antibiotics and the…
Trade and Price Differentials for Pharmaceuticals: Policy Options
1 May 1997
…countries, such as France, Spain or Greece, into countries with higher prices, such as Germany, the UK or the Netherlands. The European Court of Justice has upheld parallel importing, as…
New Report Published: Improving Efficiency and Resource Allocation in Future Cancer Care
26 September 2016
…countries (Belgium, Denmark, France, Germany, Italy, the Netherlands, Poland, Sweden, and the UK) as well as the EU27 average. The report highlights that cancer represents a significant disease burden in…
Dr Francois Maignen joins the OHE team as Head of Operational Research and Data Analysis
7 July 2016
…a doctorate in pharmacy, a post-graduation diploma in hospital pharmacy and public health and a MSc in molecular pharmacochemistry, experimental pharmacology and metabolism (Université René Descartes, Paris V, France). Francois…
Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?
29 February 2016
…with decision makers and experts in eight countries (Australia, France, Germany, Italy, Poland, South Korea, Sweden, and the United Kingdom). We found that in the eight countries examined, with the…
How to Manage Data Governance in an Era of Real World Evidence (RWE): Working Towards a Set of International Standards
24 November 2015
…for how RWD (both routinely-collected and de-novo) is accessed or generated, and used credibly to provide evidence in eight countries: the UK, France, Italy, Sweden, Germany, the Netherlands, Australia and…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…of 29 drug/indication pairs and a group of 15 countries were studied (Australia, Canada, Denmark, France, Italy, Korea, Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia, Ecuador, Egypt and Ghana). The…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
…Denmark, France, Italy, Korea, Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia, Ecuador, Egypt and Ghana). Information regarding NICE HTA recommendations was extracted from NICE’s website and HTAinSite.com, and additional information…